Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy, safety and tolerability of metadoxine
(MG01CI) extended release formulation for the treatment of adults diagnosed with ADHD